Dayah Capital LLC Decreases Stake in Ingevity Corporation $NGVT

Dayah Capital LLC lessened its stake in shares of Ingevity Corporation (NYSE:NGVT) by 27.8% during the 1st quarter, Holdings Channel reports. The firm owned 85,795 shares of the company’s stock after selling 33,094 shares during the quarter. Ingevity comprises approximately 2.3% of Dayah Capital LLC’s investment portfolio, making the stock its 11th largest position. Dayah Capital LLC’s holdings in Ingevity were worth $6,111,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of NGVT. Millennium Management LLC raised its holdings in shares of Ingevity by 1.3% in the third quarter. Millennium Management LLC now owns 1,189,524 shares of the company’s stock worth $65,650,000 after buying an additional 15,562 shares during the last quarter. Royce & Associates LP lifted its stake in shares of Ingevity by 7.7% during the fourth quarter. Royce & Associates LP now owns 1,111,158 shares of the company’s stock worth $65,758,000 after buying an additional 79,059 shares during the period. Brown Advisory Inc. grew its holdings in shares of Ingevity by 15.4% during the fourth quarter. Brown Advisory Inc. now owns 1,040,944 shares of the company’s stock valued at $61,603,000 after buying an additional 138,859 shares during the last quarter. Simcoe Capital Management LLC increased its position in shares of Ingevity by 9.4% in the 4th quarter. Simcoe Capital Management LLC now owns 1,020,945 shares of the company’s stock valued at $60,420,000 after acquiring an additional 87,490 shares during the period. Finally, Victory Capital Management Inc. increased its position in shares of Ingevity by 7.4% in the 4th quarter. Victory Capital Management Inc. now owns 867,915 shares of the company’s stock valued at $51,363,000 after acquiring an additional 60,163 shares during the period. Institutional investors and hedge funds own 91.59% of the company’s stock.

Ingevity News Roundup

Here are the key news stories impacting Ingevity this week:

• Positive Sentiment: Quarterly earnings beat expectations. Ingevity reported second-quarter EPS of $1.74, above analyst estimates ranging from $1.31 to $1.33 and up from $1.39 a year earlier. Revenue of $314.1 million also exceeded the $312.2 million consensus estimate. Ingevity Tops Q2 Earnings and Revenue Estimates
• Positive Sentiment: Full-year 2026 adjusted EPS guidance was raised. The company now expects adjusted EPS of $5.00 to $5.45, above the prior outlook and higher than the roughly $4.95-$5.05 analyst consensus range. Ingevity also increased its full-year adjusted EBITDA outlook following a solid start to the year. Ingevity’s Q2 Adjusted Earnings Increase, Net Sales Decline; 2026 Adjusted EPS Outlook Raised
• Neutral Sentiment: Revenue guidance remains broadly in line with expectations. Ingevity maintained 2026 revenue guidance of approximately $1.1 billion to $1.2 billion, compared with consensus expectations near $1.1 billion. Ingevity Reports Second Quarter 2026 Financial Results
• Negative Sentiment: Net sales declined year over year. Although quarterly revenue edged past estimates, the year-over-year sales decline creates concern about underlying demand and may offset some of the benefit from stronger earnings guidance. The company also reported a negative net margin, adding to investor caution.

Insider Buying and Selling

In other news, SVP Terrance M. Dyer sold 496 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total value of $33,971.04. Following the completion of the sale, the senior vice president directly owned 7,202 shares in the company, valued at $493,264.98. The trade was a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.88% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ingevity in a research report on Friday, July 17th. Wall Street Zen raised Ingevity from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 7th. Two research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $80.00.

Ingevity Trading Down 0.8%

Shares of Ingevity stock opened at $70.02 on Friday. The firm has a 50-day simple moving average of $71.63 and a two-hundred day simple moving average of $70.95. The company has a debt-to-equity ratio of 27.83, a quick ratio of 0.92 and a current ratio of 1.42. Ingevity Corporation has a fifty-two week low of $39.74 and a fifty-two week high of $79.29. The company has a market cap of $2.43 billion, a P/E ratio of 47.63 and a beta of 1.16.

Ingevity (NYSE:NGVT) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.41. The firm had revenue of $314.10 million during the quarter, compared to analyst estimates of $312.20 million. Ingevity had a return on equity of 261.97% and a net margin of 4.65%.Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, equities analysts predict that Ingevity Corporation will post 5.05 earnings per share for the current fiscal year.

Ingevity Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.